Literature DB >> 31558246

Extent of Myocardial Ischemia on Positron Emission Tomography and Survival Benefit With Early Revascularization.

Krishna K Patel1, John A Spertus2, Paul S Chan2, Brett W Sperry2, Randall C Thompson2, Firas Al Badarin2, Kevin F Kennedy3, James A Case4, Staci Courter4, Ibrahim M Saeed2, A Iain McGhie2, Timothy M Bateman2.   

Abstract

BACKGROUND: Prior studies with single-photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI) have shown a survival benefit with early revascularization in patients with >10% to 12.5% ischemic myocardium. The relationship among positron emission tomography (PET)-derived extent of ischemia, early revascularization, and survival is unknown.
OBJECTIVES: The purpose of this study was to evaluate the association among percent ischemia on PET MPI, revascularization, and survival.
METHODS: A total of 16,029 unique consecutive patients who were undergoing Rubidium-82 rest-stress PET MPI from 2010 to 2016 were included. Patients with known cardiomyopathy and nondiagnostic perfusion results were excluded. Percent ischemic myocardium was estimated from a 17-segment model. Propensity scoring was used to account for nonrandomized referral to early revascularization (90 days of PET). A Cox model was developed, adjusting for propensity scores for early revascularization and percent ischemia, and an interaction between ischemia and early revascularization was tested.
RESULTS: Median follow-up was 3.7 years. Overall, 1,277 (8%) patients underwent early revascularization and 2,493 (15.6%) died (738 cardiac). Nearly 37% of patients (n = 5,902) had ischemia, with 13.5% (n = 2,160) having ≥10%. In propensity-adjusted analyses, there was a significant interaction between ischemia and early revascularization (p < 0.001 for all-cause and cardiac death), such that patients with greater ischemia had improved survival with early revascularization, with a potential ischemia threshold at 5% (upper limit 95% confidence interval at 10%). There was no differential association between ischemia and early revascularization on death based on history of known coronary artery disease (interaction p = 0.72).
CONCLUSIONS: In a contemporary cohort of patients undergoing PET MPI, patients with greater ischemia had a survival benefit from early revascularization. On exploratory analyses, this threshold was lower than that previously reported for SPECT. These findings require future validation in prospective cohorts or trials.
Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  coronary revascularization; ischemia; myocardial perfusion imaging; positron emission tomography; survival

Year:  2019        PMID: 31558246      PMCID: PMC6768093          DOI: 10.1016/j.jacc.2019.07.055

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  21 in total

1.  Comparability of national death index plus and standard procedures for determining causes of death in epidemiologic studies.

Authors:  M M Doody; H M Hayes; R Bilgrad
Journal:  Ann Epidemiol       Date:  2001-01       Impact factor: 3.797

2.  Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention.

Authors:  Leslee J Shaw; William S Weintraub; David J Maron; Pamela M Hartigan; Rory Hachamovitch; James K Min; Marcin Dada; G B John Mancini; Sean W Hayes; Robert A O'Rourke; John A Spertus; William Kostuk; Gilbert Gosselin; Bernard R Chaitman; Merill Knudtson; John Friedman; Piotr Slomka; Guido Germano; Eric R Bates; Koon K Teo; William E Boden; Daniel S Berman
Journal:  Am Heart J       Date:  2012-08       Impact factor: 4.749

3.  Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revascularization vs. medical therapy among patients undergoing stress-rest myocardial perfusion scintigraphy.

Authors:  Rory Hachamovitch; Alan Rozanski; Leslee J Shaw; Gregg W Stone; Louise E J Thomson; John D Friedman; Sean W Hayes; Ishac Cohen; Guido Germano; Daniel S Berman
Journal:  Eur Heart J       Date:  2011-01-21       Impact factor: 29.983

4.  Optimal medical therapy with or without PCI for stable coronary disease.

Authors:  William E Boden; Robert A O'Rourke; Koon K Teo; Pamela M Hartigan; David J Maron; William J Kostuk; Merril Knudtson; Marcin Dada; Paul Casperson; Crystal L Harris; Bernard R Chaitman; Leslee Shaw; Gilbert Gosselin; Shah Nawaz; Lawrence M Title; Gerald Gau; Alvin S Blaustein; David C Booth; Eric R Bates; John A Spertus; Daniel S Berman; G B John Mancini; William S Weintraub
Journal:  N Engl J Med       Date:  2007-03-26       Impact factor: 91.245

5.  Impact of left ventricular function and the extent of ischemia and scar by stress myocardial perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.

Authors:  Leslee J Shaw; Manuel D Cerqueira; Maria M Brooks; Andrew D Althouse; Veronica V Sansing; George A Beller; Rodica Pop-Busui; Raymond Taillefer; Bernard R Chaitman; Raymond J Gibbons; Jaekyeong Heo; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2012-04-19       Impact factor: 5.952

6.  Fractional flow reserve versus angiography for guiding percutaneous coronary intervention.

Authors:  Pim A L Tonino; Bernard De Bruyne; Nico H J Pijls; Uwe Siebert; Fumiaki Ikeno; Marcel van' t Veer; Volker Klauss; Ganesh Manoharan; Thomas Engstrøm; Keith G Oldroyd; Peter N Ver Lee; Philip A MacCarthy; William F Fearon
Journal:  N Engl J Med       Date:  2009-01-15       Impact factor: 91.245

7.  Incremental prognostic value of gated Rb-82 positron emission tomography myocardial perfusion imaging over clinical variables and rest LVEF.

Authors:  Sharmila Dorbala; Rory Hachamovitch; Zelmira Curillova; Deepak Thomas; Divya Vangala; Raymond Y Kwong; Marcelo F Di Carli
Journal:  JACC Cardiovasc Imaging       Date:  2009-07

8.  Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography.

Authors:  Rory Hachamovitch; Sean W Hayes; John D Friedman; Ishac Cohen; Daniel S Berman
Journal:  Circulation       Date:  2003-05-27       Impact factor: 29.690

9.  A randomized trial of therapies for type 2 diabetes and coronary artery disease.

Authors:  Robert L Frye; Phyllis August; Maria Mori Brooks; Regina M Hardison; Sheryl F Kelsey; Joan M MacGregor; Trevor J Orchard; Bernard R Chaitman; Saul M Genuth; Suzanne H Goldberg; Mark A Hlatky; Teresa L Z Jones; Mark E Molitch; Richard W Nesto; Edward Y Sako; Burton E Sobel
Journal:  N Engl J Med       Date:  2009-06-07       Impact factor: 91.245

10.  Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.

Authors:  Leslee J Shaw; Daniel S Berman; David J Maron; G B John Mancini; Sean W Hayes; Pamela M Hartigan; William S Weintraub; Robert A O'Rourke; Marcin Dada; John A Spertus; Bernard R Chaitman; John Friedman; Piotr Slomka; Gary V Heller; Guido Germano; Gilbert Gosselin; Peter Berger; William J Kostuk; Ronald G Schwartz; Merill Knudtson; Emir Veledar; Eric R Bates; Benjamin McCallister; Koon K Teo; William E Boden
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690

View more
  11 in total

1.  Optimizing patient centered care in the cardiac intensive care unit: Harness the safety, effectiveness, and incremental value of radionuclide perfusion, function, and molecular imaging.

Authors:  Peter A Bleszynski; Ronald G Schwartz
Journal:  J Nucl Cardiol       Date:  2021-06-24       Impact factor: 5.952

2.  Nuclear cardiology in the information age.

Authors:  Sharmila Dorbala
Journal:  J Nucl Cardiol       Date:  2020-02       Impact factor: 5.952

Review 3.  Utility of nuclear cardiovascular imaging in the cardiac intensive care unit.

Authors:  Aldo L Schenone; Erika Hutt; Paul Cremer; Wael A Jaber
Journal:  J Nucl Cardiol       Date:  2021-06-09       Impact factor: 5.952

Review 4.  A Narrative Review of the Classical and Modern Diagnostic Methods of the No-Reflow Phenomenon.

Authors:  Larisa Renata Pantea-Roșan; Simona Gabriela Bungau; Andrei-Flavius Radu; Vlad Alin Pantea; Mădălina Ioana Moisi; Cosmin Mihai Vesa; Tapan Behl; Aurelia Cristina Nechifor; Elena Emilia Babes; Manuela Stoicescu; Daniela Gitea; Diana Carina Iovanovici; Cristiana Bustea
Journal:  Diagnostics (Basel)       Date:  2022-04-08

5.  Relative Prognostic Significance of Positron Emission Tomography Myocardial Perfusion Imaging Markers in Cardiomyopathy.

Authors:  Merrill Thomas; Brett W Sperry; Poghni Peri-Okonny; Ali O Malik; A Iain McGhie; Ibrahim M Saeed; Paul S Chan; John A Spertus; Randall C Thompson; Timothy M Bateman; Krishna K Patel
Journal:  Circ Cardiovasc Imaging       Date:  2021-10-19       Impact factor: 8.589

6.  Impact of Early Revascularization on Major Adverse Cardiovascular Events in Relation to Automatically Quantified Ischemia.

Authors:  Peyman N Azadani; Robert J H Miller; Tali Sharir; Marcio A Diniz; Lien-Hsin Hu; Yuka Otaki; Heidi Gransar; Joanna X Liang; Evann Eisenberg; Andrew J Einstein; Mathews B Fish; Terrence D Ruddy; Philipp A Kaufmann; Albert J Sinusas; Edward J Miller; Timothy M Bateman; Sharmila Dorbala; Marcelo Di Carli; Balaji K Tamarappoo; Damini Dey; Daniel S Berman; Piotr J Slomka
Journal:  JACC Cardiovasc Imaging       Date:  2020-08-19

Review 7.  Reliability and Reproducibility of Absolute Myocardial Blood Flow: Does It Depend on the PET/CT Technology, the Vasodilator, and/or the Software?

Authors:  K Lance Gould; Linh Bui; Danai Kitkungvan; Monica B Patel
Journal:  Curr Cardiol Rep       Date:  2021-01-22       Impact factor: 2.931

Review 8.  Coronary Revascularization and Long-Term Survivorship in Chronic Coronary Syndrome.

Authors:  Ana Gabaldon-Perez; Victor Marcos-Garces; Jose Gavara; Cesar Rios-Navarro; Gema Miñana; Antoni Bayes-Genis; Oliver Husser; Juan Sanchis; Julio Nunez; Francisco Javier Chorro; Vicente Bodi
Journal:  J Clin Med       Date:  2021-02-05       Impact factor: 4.241

9.  Evaluation of Stress Cardiac Magnetic Resonance Imaging in Risk Reclassification of Patients With Suspected Coronary Artery Disease.

Authors:  Panagiotis Antiochos; Yin Ge; Kevin Steel; Yi-Yun Chen; Scott Bingham; Shuaib Abdullah; J Ronald Mikolich; Andrew E Arai; W Patricia Bandettini; Amit R Patel; Afshin Farzaneh-Far; John F Heitner; Chetan Shenoy; Steve W Leung; Jorge A Gonzalez; Dipan J Shah; Subha V Raman; Victor A Ferrari; Jeanette Schulz-Menger; Matthias Stuber; Orlando P Simonetti; Venkatesh L Murthy; Raymond Y Kwong
Journal:  JAMA Cardiol       Date:  2020-12-01       Impact factor: 14.676

10.  The year in cardiology: coronary interventions.

Authors:  Andreas Baumbach; Christos V Bourantas; Patrick W Serruys; William Wijns
Journal:  Eur Heart J       Date:  2020-01-14       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.